V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005528 | 280003514 | 1.71 | 57.9 | Palliative (P) | 2016-11-26 | 2016-11-27 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280029268 | OXALIPLATIN + MDG |
| 280005529 | 280003515 | 1.67 | 94.5 | Palliative (P) | 2013-08-03 | 2013-08-17 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | 280029270 | OXALIPLATIN + MDG |
| 280005530 | 280003516 | 1.63 | 72.6 | Curative (C) | null | 2017-05-26 | FEC + DOCETAXEL | 2 | null | 280029271 | CAPECITABINE + OXALIPLATIN |
| 280005531 | 280003516 | null | 56.9 | Curative (C) | null | 2013-07-01 | AFLIBERCEPT + FU + IRINOTECAN | null | null | 280029271 | LANREOTIDE |
| 280005532 | 280003517 | 1.84 | 77.6 | Curative (C) | 2017-05-30 | 2017-06-05 | IVA | N | N | 280029273 | BEP |
| 280005533 | 280003517 | 1.5 | 68 | Palliative (P) | 2017-05-18 | 2017-06-07 | DABRAFENIB + TRAMETINIB | 2 | N | 280029273 | CISPLATIN + EPIRUBICIN |
| 280005534 | 280003518 | 1.83 | null | Palliative (P) | 2015-10-11 | 2015-10-22 | DE-ESCALATE TRIAL | N | N | 280029276 | OXALIPLATIN + MDG |
| 280005535 | 280003519 | 1.83 | null | Palliative (P) | 2016-04-16 | 2016-04-19 | GemCarbo Days 1+8 | N | N | 280029277 | CAPECITABINE |
| 280005536 | 280003519 | 1.79 | 82.4 | null | 2018-01-09 | 2018-01-12 | BCG Intravesical | N | N | 280029277 | DACARBAZINE |
| 280005537 | 280003520 | 1.73 | 82 | Palliative (P) | 2017-02-23 | 2017-03-05 | Cisplatin + Pemetrexed | N | N | 280029280 | DABRAFENIB + TRAMETINIB |
| 280005538 | 280003521 | null | 92.999 | null | 2015-09-01 | 2015-09-15 | Capecitabine (21days) + Carboplatin | N | null | 280029281 | GEMCARBO |
| 280005539 | 280003521 | 0 | 38.8 | Curative (C) | 2017-03-02 | 2017-04-07 | CISPLATIN + ETOPOSIDE | 02 | N | 280029281 | BEP |
| 280005540 | 280003522 | 1.63 | 93.4 | Palliative (P) | 2017-03-01 | 2017-03-11 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | 280029283 | ABC-03 TRIAL |
| 280005541 | 280003523 | 1.52 | 0 | Palliative (P) | 2016-02-12 | 2016-02-12 | PEMBROLIZUMAB | 02 | null | 280029284 | HCX |
| 280005542 | 280003523 | null | 60.5 | Palliative (P) | 2016-01-28 | 2016-02-07 | Irinotecan + Modified De Gramont | N | N | 280029284 | LANREOTIDE |
| 280005543 | 280003524 | null | 73.2 | null | 2015-04-03 | 2015-04-04 | CETUXIMAB + IRINOTECAN + MDG | Y | N | 280029287 | GEMCARBO |
| 280005544 | 280003525 | 1.72 | 0 | Adjuvant (A) | 2015-08-22 | 2015-09-04 | IMATINIB | 2 | N | 280029288 | OXALIPLATIN + MDG |
| 280005545 | 280003525 | 1.63 | 57.6 | Palliative (P) | null | 2017-12-12 | GemCarbo Days 1+8 | N | N | 280029288 | MPT |
| 280005546 | 280003526 | null | 87.4 | Palliative (P) | 2013-07-18 | 2014-11-14 | LANREOTIDE | N | N | 280029292 | IPILIMUMAB |
| 280005547 | 280003527 | 1.64 | 63.3 | Palliative (P) | 2015-10-16 | 2015-10-23 | CAPECITABINE + RT | N | N | 280029293 | LANREOTIDE |
| 280005548 | 280003528 | 1.68 | 47.7 | Palliative (P) | 2014-01-30 | 2014-06-08 | Capecitabine + Oxaliplatin 21day | 02 | N | 280029294 | CARBOPLATIN + LIPOSOMAL DOX |
| 280005549 | 280003529 | 1.77 | 17.7 | Palliative (P) | 2017-07-23 | 2017-09-01 | Gemcitabine weekly | null | N | 280029297 | PAZOPANIB |
| 280005550 | 280007875 | null | null | Palliative (P) | 2017-06-21 | 2017-06-25 | Carboplatin + Pemetrexed | N | N | 280029299 | OXALIPLATIN + MDG |
| 280005551 | 280007875 | 1.56 | null | null | 2015-03-29 | 2015-03-29 | Gemcitabine 1000mg/m2 D1 8 15 | N | null | 280029299 | ECX |
| 280005552 | 280003530 | 1.68 | 50.1 | Palliative (P) | 2013-08-07 | 2013-08-10 | Capecitabine + Oxaliplatin 21day | N | N | 280029302 | CYCLOPHOSPHAMIDE |
| 280005553 | 280003530 | null | 60 | Palliative (P) | null | 2015-11-18 | VIDE | N | N | 280029302 | OXALIPLATIN + MDG |
| 280005554 | 280003531 | 1.74 | 74.8 | Palliative (P) | 2016-12-28 | 2017-01-09 | Oxaliplatin + Modified de Gramont | N | N | 280029304 | GEMCITABINE |
| 280005555 | 280003531 | null | 10.4 | Palliative (P) | 2015-09-21 | 2015-09-28 | Mitomycin Intravesical | Y | Y | 280029304 | LANREOTIDE |
| 280005556 | 280003532 | 1.7 | 89 | null | null | 2016-08-15 | BCG Intravesical | Y | null | 280029307 | MITOMYCIN INTRAVESICULAR |
| 280005557 | 280003532 | null | 82.25 | Palliative (P) | 2017-12-06 | 2017-12-06 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | null | null | 280029307 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 280005558 | 280003533 | 1.7 | 103.4 | Palliative (P) | 2013-08-09 | 2013-08-13 | Carboplatin + Pemetrexed | 2 | N | 280029309 | GEMCARBO |
| 280005559 | 280003533 | 1.73 | null | null | null | 2017-03-04 | Carboplatin + Vinorelbine Oral | null | null | 280029309 | MITOMYCIN INTRAVESICULAR |
| 280005560 | 280003534 | 1.66 | 72.15 | null | 2014-01-24 | 2014-02-06 | GEMCARBO | 02 | N | 280029311 | CAPECITABINE + OXALIPLATIN |
| 280005561 | 280003534 | null | 79.5 | Palliative (P) | null | 2017-08-31 | Carboplatin + Pemetrexed | null | null | 280029311 | GEMCARBO |
| 280005562 | 280003535 | 1.49 | 55.3 | Palliative (P) | 2017-01-31 | 2017-05-23 | PEMBROLIZUMAB | N | N | 280029313 | LANREOTIDE |
| 280005563 | 280007881 | 1.8 | 73.1 | Neo-adjuvant (N) | 2015-04-30 | 2015-05-19 | LANREOTIDE | N | N | 280029317 | OXALIPLATIN + MDG |
| 280005564 | 280003536 | 1.8 | null | Palliative (P) | null | 2017-04-11 | ETOPOSIDE | null | null | 280029318 | OXALIPLATIN + MDG |
| 280005565 | 280003536 | 1.7 | 0 | Curative (C) | 2014-04-12 | 2014-04-19 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 280029318 | CAPECITABINE + OXALIPLATIN |
| 280005566 | 280003537 | 1.59 | 80.55 | Palliative (P) | 2017-11-17 | 2017-12-08 | VIDE | N | null | 280029321 | GEMCITABINE |
| 280005567 | 280003537 | 1.82 | null | Curative (C) | 2013-07-13 | 2013-07-13 | Y-90 | N | N | 280029321 | BEP |
| 280005568 | 280003538 | 1.76 | 66.6 | Palliative (P) | 2013-10-21 | 2013-10-25 | Cetuximab +Cisplatin + FU (Cycle 1) | N | null | 280029326 | ECX |
| 280005569 | 280003538 | null | null | null | null | 2015-01-15 | Bevacizumab + CAPECITABINE + OXALIPLATIN | null | null | 280029326 | OCTREOTIDE |
| 280005570 | 280003539 | 1.59 | 90.3 | Palliative (P) | 2016-07-03 | 2016-07-03 | Capecitabine + Oxaliplatin 21day | N | N | 280029328 | LANREOTIDE |
| 280005571 | 280003540 | 1.57 | 99.95 | null | 2017-12-14 | 2018-01-03 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 280029329 | HYDROXYCARBAMIDE |
| 280005572 | 280003540 | 1.97 | 65.9 | Palliative (P) | 2015-01-26 | 2015-01-26 | IVA | 02 | N | 280029329 | ECX |
| 280005573 | 280003540 | 1.73 | 60 | Palliative (P) | 2015-02-03 | 2015-02-20 | ECX | N | N | 280029329 | CAPECITABINE + OXALIPLATIN |
| 280005574 | 280003541 | 1.75 | 87.3 | Palliative (P) | 2016-09-27 | 2016-09-28 | Bortezomib + Cyclophos + Dex | 02 | N | 280029334 | GEMCARBO |
| 280005575 | 280003541 | 1.65 | null | Palliative (P) | 2018-08-05 | 2018-08-16 | EW EuroEwing 2012 Arm A VIDE | N | N | 280029334 | DACARBAZINE |
| 280005576 | 280003541 | 1.61 | 66 | Palliative (P) | 2017-12-02 | 2017-12-03 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 2 | N | 280029334 | CAPECITABINE |
| 280005577 | 280003541 | 1.61 | 68 | Palliative (P) | 2015-04-10 | 2015-04-25 | Capecitabine + Cisplatin | 02 | N | 280029334 | FCIST |